From Immune Dysregulations to Therapeutic Perspectives in Myelodysplastic Syndromes: A Review
The pathophysiology of myelodysplastic syndromes (MDSs) is complex and often includes immune dysregulation of both the innate and adaptive immune systems. Whereas clonal selection mainly involves smoldering inflammation, a cellular immunity dysfunction leads to increased apoptosis and blast prolifer...
Guardado en:
Autores principales: | Thibault Comont, Emmanuel Treiner, François Vergez |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eafaa3a4705946218f780915a470f3a7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Transitory response of a myelodysplastic syndrome with deletion of chromosome 5q to thalidomide. Report of one case
por: Palacios-Campos,Adriana, et al.
Publicado: (2020) -
Histiocytoid Sweet’s syndrome in a patient with myelodysplastic syndrome: report and review of the literature
por: Michael M. Shalaby, et al.
Publicado: (2016) -
Thoracic Purpura in a Patient With Myelodysplastic Syndrome
por: Nuno Gomes, et al.
Publicado: (2021) -
Phenotypic and functional changes of NK cells in patients with myelodysplastic syndrome and acute myeloid leukemia treated with hypomethylating drugs
por: D. I. Zhigarev, et al.
Publicado: (2021) -
Lymphocytic Infiltrate and p53 Protein Expression as Predictive Markers of Response and Outcome in Myelodysplastic Syndromes Treated with Azacitidine
por: Carlo Pescia, et al.
Publicado: (2021)